Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report

Primary Breast Lymphoma (PBL) is an uncommon form of Non Hodgkin Lymphoma (NHL) that arises within the breast tissue, representing less than 1-2% of all cases of NHL and under 0.5% of all breast cancers. Most PBL cases are of the B-cell type, accounting for up to 50% of all PBL. Diffuse Large B-cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Sneha Samir Babaria, Jinalben Shaileshbhai Patel
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/20503/76054_CE[Ra1]_F(SHU)_QC(PS_OM)_PF1(AG_SS)_PFA_NC(IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593578875944960
author Sneha Samir Babaria
Jinalben Shaileshbhai Patel
author_facet Sneha Samir Babaria
Jinalben Shaileshbhai Patel
author_sort Sneha Samir Babaria
collection DOAJ
description Primary Breast Lymphoma (PBL) is an uncommon form of Non Hodgkin Lymphoma (NHL) that arises within the breast tissue, representing less than 1-2% of all cases of NHL and under 0.5% of all breast cancers. Most PBL cases are of the B-cell type, accounting for up to 50% of all PBL. Diffuse Large B-cell Lymphoma (DLBCL) of the breast is a rare subtype of NHL, with a common age of presentation in females being 50-60 years. It typically presents as a painless breast mass without pathognomonic radiologic findings. Authors hereby, report a case of a 43-year-old female who complained only of heaviness in the right breast, followed by a discretely palpable lump upon examination. High-grade NHL was diagnosed via core needle biopsy and turned out to be DLBCL, Activated B-cell (ABC)-like subtype, as determined by Immunohistochemistry (IHC). This study emphasises that histopathological analysis of core needle biopsy with IHC is paramount for establishing the diagnosis and distinguishing it from other benign and malignant breast conditions. By sharing this case, authors aimed to contribute to the growing knowledge of this rare entity, which has steadily increased over the past four decades, to ensure timely and accurate diagnosis for the implementation of appropriate therapy.
format Article
id doaj-art-de591a75a94a44a1b0de199420ec41f6
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-01-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-de591a75a94a44a1b0de199420ec41f62025-01-20T11:35:05ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-01-011901010310.7860/JCDR/2025/76054.20503Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case ReportSneha Samir Babaria0Jinalben Shaileshbhai Patel1Associate Professor, Department of Pathology, Dr. N. D. Desai Faculty of Medical Science and Research, Dharmsinh Desai University, Nadiad, Gujarat, India.Senior Resident, Department of Pathology, Narendra Modi Medical College, Maninagar, Ahmedabad, Gujarat, India.Primary Breast Lymphoma (PBL) is an uncommon form of Non Hodgkin Lymphoma (NHL) that arises within the breast tissue, representing less than 1-2% of all cases of NHL and under 0.5% of all breast cancers. Most PBL cases are of the B-cell type, accounting for up to 50% of all PBL. Diffuse Large B-cell Lymphoma (DLBCL) of the breast is a rare subtype of NHL, with a common age of presentation in females being 50-60 years. It typically presents as a painless breast mass without pathognomonic radiologic findings. Authors hereby, report a case of a 43-year-old female who complained only of heaviness in the right breast, followed by a discretely palpable lump upon examination. High-grade NHL was diagnosed via core needle biopsy and turned out to be DLBCL, Activated B-cell (ABC)-like subtype, as determined by Immunohistochemistry (IHC). This study emphasises that histopathological analysis of core needle biopsy with IHC is paramount for establishing the diagnosis and distinguishing it from other benign and malignant breast conditions. By sharing this case, authors aimed to contribute to the growing knowledge of this rare entity, which has steadily increased over the past four decades, to ensure timely and accurate diagnosis for the implementation of appropriate therapy.https://jcdr.net/articles/PDF/20503/76054_CE[Ra1]_F(SHU)_QC(PS_OM)_PF1(AG_SS)_PFA_NC(IS)_PN(IS).pdfbreast lymphomanon hodgkin lymphomaprimary breast lymphoma
spellingShingle Sneha Samir Babaria
Jinalben Shaileshbhai Patel
Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
Journal of Clinical and Diagnostic Research
breast lymphoma
non hodgkin lymphoma
primary breast lymphoma
title Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
title_full Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
title_fullStr Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
title_full_unstemmed Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
title_short Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
title_sort breast diffuse large b cell lymphoma activated b cell like subtype a case report
topic breast lymphoma
non hodgkin lymphoma
primary breast lymphoma
url https://jcdr.net/articles/PDF/20503/76054_CE[Ra1]_F(SHU)_QC(PS_OM)_PF1(AG_SS)_PFA_NC(IS)_PN(IS).pdf
work_keys_str_mv AT snehasamirbabaria breastdiffuselargebcelllymphomaactivatedbcelllikesubtypeacasereport
AT jinalbenshaileshbhaipatel breastdiffuselargebcelllymphomaactivatedbcelllikesubtypeacasereport